Skip to main content

Advertisement

SpringerLink
Log in

Simvastatin enhances radiation sensitivity of colorectal cancer cells

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Introduction

Neoadjuvant chemoradiation (CRT) for rectal cancer induces variable responses, and better response has been associated with improved oncologic outcomes. Our group has previously shown that the administration of HMG-CoA reductase inhibitors, commonly known as statins, is associated with improved response to neoadjuvant CRT in rectal cancer patients. The purpose of this study was to study the effects of simvastatin on colorectal cancer cells and explore its potential as a radiation-sensitizer in vitro.

Methods

Four colorectal cancer cell lines (SW480, DLD1, SW837, and HRT18) were used to test the effects of simvastatin alone, radiation alone, and combination therapy. Outcome measures included ATP-based cell viability, colony formation, and protein (immunoblot) assays.

Results

The combination of radiation and simvastatin inhibited colony formation and cell viability of all four CRC lines, to a greater degree than either treatment alone (p < 0.01). In addition, the effects of simvastatin in this combination therapy were dose dependent, with increased concentrations resulting in more potentiated inhibitory effects. The radiosensitizing effects of simvastatin on cell viability were negated by the presence of exogenous GGPP in the media. On protein analyses of irradiated cells, simvastatin treatment inhibited phosphorylation of ERK1/2, in a dose-dependent manner, while the total levels of ERK1/2 remained stable. In addition, the combined treatment resulted in increased levels of cleaved caspase 3, indicating greater apoptotic activity in the cells treated with radiation and simvastatin together.

Conclusions

Treatment with simvastatin hindered CRC cell viability and enhanced radiation sensitivity in vitro. These effects were tied to the depletion of GGPP and the decreased phosphorylation of ERK1/2, suggesting a prominent role for the EGFR-RAS-ERK1/2 pathway, through which statin enhances radiation sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. O’Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331(8):502–507. doi:10.1056/nejm199408253310803

    Article  PubMed  Google Scholar 

  2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646. doi:10.1056/NEJMoa010580

    Article  CAS  PubMed  Google Scholar 

  3. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740. doi:10.1056/NEJMoa040694

    Article  CAS  PubMed  Google Scholar 

  4. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rodel C (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933. doi:10.1200/jco.2011.40.1836

    Article  CAS  PubMed  Google Scholar 

  5. Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23(34):8688–8696. doi:10.1200/jco.2005.02.1329

    Article  PubMed  Google Scholar 

  6. Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, Calvo FA, Garcia-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W Jr, Suarez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835–844. doi:10.1016/s1470-2045(10)70172-8

    Article  PubMed  Google Scholar 

  7. Mace AG, Pai RK, Stocchi L, Kalady MF (2015) American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum 58(1):32–44. doi:10.1097/dcr.0000000000000266

    Article  PubMed  Google Scholar 

  8. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 5(8):2223–2229

    CAS  PubMed  Google Scholar 

  9. Chan KK, Oza AM, Siu LL (2003) The statins as anticancer agents. Clin Cancer Res 9(1):10–19

    CAS  PubMed  Google Scholar 

  10. Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ (2004) The risk of cancer in users of statins. J Clin Oncol 22(12):2388–2394. doi:10.1200/jco.2004.02.027

    Article  CAS  PubMed  Google Scholar 

  11. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G (2005) Statins and the risk of colorectal cancer. N Engl J Med 352(21):2184–2192. doi:10.1056/NEJMoa043792

    Article  CAS  PubMed  Google Scholar 

  12. Mace AG, Gantt GA, Skacel M, Pai R, Hammel JP, Kalady MF (2013) Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer. Dis Colon Rectum 56(11):1217–1227. doi:10.1097/DCR.0b013e3182a4b236

    Article  PubMed  Google Scholar 

  13. Katz MS, Minsky BD, Saltz LB, Riedel E, Chessin DB, Guillem JG (2005) Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 62(5):1363–1370. doi:10.1016/j.ijrobp.2004.12.033

    Article  CAS  PubMed  Google Scholar 

  14. Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG (2007) Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 6(7):541–555. doi:10.1038/nrd2221

    Article  CAS  PubMed  Google Scholar 

  15. Huang EH, Johnson LA, Eaton K, Hynes MJ, Carpentino JE, Higgins PD (2010) Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice. Dig Dis Sci 55(11):3086–3094. doi:10.1007/s10620-010-1157-x

    Article  CAS  PubMed  Google Scholar 

  16. Lee SJ, Lee I, Lee J, Park C, Kang WK (2014) Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90alpha in human colorectal cancer. Br J Cancer 111(3):497–505. doi:10.1038/bjc.2014.283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lee J, Lee I, Han B, Park JO, Jang J, Park C, Kang WK (2011) Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations. J Natl Cancer Inst 103(8):674–688. doi:10.1093/jnci/djr070

    Article  CAS  PubMed  Google Scholar 

  18. Lee J, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, Cho YB, Lee WY, Yun SH, Kim HC, Park YS, Kang WK (2014) Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab. Invest New Drugs 32(3):535–541. doi:10.1007/s10637-014-0065-x

    Article  CAS  PubMed  Google Scholar 

  19. Kodach LL, Jacobs RJ, Voorneveld PW, Wildenberg ME, Verspaget HW, van Wezel T, Morreau H, Hommes DW, Peppelenbosch MP, van den Brink GR, Hardwick JC (2011) Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway. Gut 60(11):1544–1553. doi:10.1136/gut.2011.237495

    Article  CAS  PubMed  Google Scholar 

  20. Lacerda L, Reddy JP, Liu D, Larson R, Li L, Masuda H, Brewer T, Debeb BG, Xu W, Hortobagyi GN, Buchholz TA, Ueno NT, Woodward WA (2014) Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med 3(7):849–856. doi:10.5966/sctm.2013-0204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sanli T, Liu C, Rashid A, Hopmans SN, Tsiani E, Schultz C, Farrell T, Singh G, Wright J, Tsakiridis T (2011) Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression. J Thorac Oncol 6(3):439–450. doi:10.1097/JTO.0b013e3182049d8b

    Article  PubMed  Google Scholar 

  22. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS (2002) T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45(7):895–903

    Article  PubMed  Google Scholar 

  23. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM (2005) Statins and cancer prevention. Nat Rev Cancer 5(12):930–942. doi:10.1038/nrc1751

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Georgios Karagkounis is the recipient of the 2015 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Career Development Award (CDA) and the American Society of Colon and Rectal Surgeons (ASCRS) General Surgery Resident Research Initiation Grant #25. Matthew F. Kalady is the Krause-Lieberman Chair in Colorectal Surgery.

Funding

This study was funded in part by the 2015 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Career Development Award and the American Society of Colon and Rectal Surgeons (ASCRS) General Surgery Resident Research Initiation Grant #25 to Georgios Karagkounis.

Author information

Authors and Affiliations

  1. Department of Colorectal Surgery, Cleveland Clinic, 9500 Euclid Avenue, A30, Cleveland, OH, 44195, USA

    Georgios Karagkounis & Matthew F. Kalady

  2. Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland, OH, USA

    Georgios Karagkounis, Jennifer DeVecchio, Sylvain Ferrandon & Matthew F. Kalady

Authors
  1. Georgios Karagkounis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer DeVecchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sylvain Ferrandon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthew F. Kalady
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew F. Kalady.

Ethics declarations

Disclosures

Georgios Karagkounis, Jennifer DeVecchio, Sylvain Ferrandon, and Matthew F. Kalady have no conflicts of interest or financial ties to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karagkounis, G., DeVecchio, J., Ferrandon, S. et al. Simvastatin enhances radiation sensitivity of colorectal cancer cells. Surg Endosc 32, 1533–1539 (2018). https://doi.org/10.1007/s00464-017-5841-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-017-5841-1

Keywords

Search

Navigation